RBC Capital Raises UnitedHealth (UNH) Price Target to $498
Key Points
- RBC Capital reiterated its Outperform rating on UnitedHealth Group Incorporated on October 20, 2026, raising its price target to $498.00 from $478.00.
- RBC Capital's $498 price target implies 18.93% upside from UnitedHealth Group Incorporated's ($UNH) current $418.72 share price.
- UnitedHealth shares recently traded around $418.72 on October 20, 2026, sitting about 9.3% below their 52-week high.
- Wall Street maintains an overall buy consensus on the healthcare giant as investors look toward the next earnings update on January 12, 2027.
Get UnitedHealth Group Incorporated text alerts
We text you when insiders, Congress, analysts or big funds move on $UNH.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures
RBC Capital reaffirmed its Outperform rating on UnitedHealth Group Incorporated on October 20, 2026, while lifting its price target from $478.00 to $498.00. The note came via a research update on the same day the stock closed at $419.57. The firm maintains its positive view on the healthcare provider's long-term business drivers across its insurance and health services operations.
UNH
UnitedHealth Group Incorporated
RBC Capital vs. the S&P 500
Hypothetical returns from RBC Capital's disclosed trades, not real profit or advice. How we model this.
RBC Capital's Call on UnitedHealth Group
RBC Capital's decision to raise its price target follows a string of recent updates from Wall Street research firms covering the healthcare provider. On October 16, 2026, Bernstein maintained an Outperform rating while adjusting its target to $500.00, and JP Morgan kept an Overweight rating with a target of $524.00. Earlier in the month, Piper Sandler and TD Cowen also issued updates on the stock. Across 25 analyst opinions tracked by the company, the consensus recommendation stands at a buy with a mean price target of $477.04.
Other Institutional Activity in UnitedHealth Group
Global Strategic Investment Solutions trimmed its holdings completely, shedding 522 shares to finish with zero shares valued at $0 in a filing reported on October 16, 2026.
UnitedHealth Group Incorporated Stock Up 4.3%
UnitedHealth shares recently traded around $418.72 as of October 20, 2026, sitting about 9.3% below their 52-week high of $461.62 and well above the 50-day moving average of $387.29. The healthcare plan provider carries a market capitalization of roughly $365.2 billion and a trailing price-to-earnings ratio of 26.17.
$UNH price target
UnitedHealth Group Incorporated daily closes and this analyst's $498 target. Not advice.
Recent Earnings
UnitedHealth reported trailing-twelve-month revenue of $450.06 billion alongside earnings of $15.55 per share. The company posted a net margin of 3.5% and a return on equity of 15.8%, with year-over-year revenue changing by -0.4%. The next quarterly earnings report is scheduled for January 12, 2027.
Dividend
The company pays an annual dividend rate of $9.28 per share, giving it a dividend yield of 2.28% based on recent trading levels. That payout is supported by a dividend payout ratio of 57.6% of earnings.
Insider Buying and Selling at UnitedHealth Group Incorporated
Officer Patrick Hugh Conway completed two sales during August 2026. The insider sold 500 shares on August 5 at an average price of $410.00 for a total value of $205,000.00, followed by another sale of 1,169 shares on August 21 at an average price of $390.00 for a total value of $455,910.00.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally through four segments, including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The enterprise provides care delivery, wellness programs, and health financial services to millions of consumers and commercial clients.
Bottom Line
Investors will be tracking the company's operational performance and healthcare cost trends ahead of the next earnings report on January 12, 2027. Analyst adjustments like RBC Capital's higher price target highlight ongoing attention to the stock's valuation relative to its broader peer group.
Related Filing Alerts
Source: RBC Capital's rating change on $UNH (Oct 20, 2026). Written by software, not financial advice. How we make alerts